Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1471-2466
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Epidemiology and comorbidities in idiopathic pulmonary fibrosis: a nationwide cohort study ; volume:23 ; number:1 ; day:4 ; month:2 ; year:2023 ; pages:1-10 ; date:12.2023
BMC pulmonary medicine ; 23, Heft 1 (4.2.2023), 1-10, 12.2023
- Creator
-
Lee, Jang Ho
Park, Hyung Jun
Kim, Seonok
Kim, Ye-Jee
Kim, Ho Cheol
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.1186/s12890-023-02340-8
- URN
-
urn:nbn:de:101:1-2023040909043454415417
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:47 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Lee, Jang Ho
- Park, Hyung Jun
- Kim, Seonok
- Kim, Ye-Jee
- Kim, Ho Cheol
- SpringerLink (Online service)
Other Objects (12)
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
Idiopathic pulmonary fibrosis: moving forward
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
Idiopathic pulmonary fibrosis: moving forward
Mental comorbidities in adolescents and young adults with juvenile idiopathic arthritis: an analysis of German nationwide health insurance data
Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
Effect of smoking and comorbidities on survival in idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis for Cardiologists: Differential Diagnosis, Cardiovascular Comorbidities, and Patient Management
Genome-wide assessment of shared genetic landscape of idiopathic pulmonary fibrosis and its comorbidities
Idiopathic pulmonary fibrosis
Idiopathic Pulmonary Fibrosis
Smoking status and clinical outcome in idiopathic pulmonary fibrosis: a nationwide study
Efficacy and safety of nintedanib in patients with idiopathic pulmonary fibrosis who are elderly or have comorbidities
Predicting survival of patients with idiopathic pulmonary fibrosis using GAP score: a nationwide cohort study
Recombinant human soluble thrombomodulin for acute exacerbation of idiopathic pulmonary fibrosis: a nationwide observational study
Idiopathic pulmonary fibrosis: moving forward